Repros Therapeutics Inc. logo

Repros Therapeutics Inc.

Sector: 
Manufacturing
   

Industry: 
Medicinal and Botanical Manufacturing

42.45
 
USD
  
-0.06
  
(-0.14%)
Optionable: Yes  Market Cap: 18,488 M  90-day average vol: 0

Previous close: 42.51  Open: 42.5  Bid: 43.5  Ask: 43.5
52 week range    
0.00   
   0.00
Peers   
ANIP / 
ABT / 
LLY / 
Last updated: Monday 8th August 2022

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABT

0.0147225 B32.4128.05

ANIP

1 B-22.139.49

LLY

0.0161238 B37.4243.55

SPHS

Chart
News
Royalty Pharma reports Q4 results
Seeking Alpha 2/15/2022
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 60.7


Financials

RPRX Income Statement

Annual

Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21
Total revenues1,598 M1,795 M1,814 M2,122 M2,289 M
Cost of sales-33 M-33 M-24 M-23 M-23 M
Gross operating profit1,598 M1,795 M1,814 M2,122 M2,289 M
Selling Gen & administrative expense507 M5 M-916 M478 M636 M
Research & development expense118 M393 M83 M26 M200 M
Operating income940 M1,364 M2,623 M1,595 M1,431 M
floaterest income00000
floaterest expense00000
Other income net644 M409 M84 M235 M-77 M
Pre-tax Income (EBT)1,343 M1,518 M2,461 M1,702 M1,241 M
Income taxes00000
Net income from total operations1,343 M1,518 M2,461 M1,702 M1,241 M
Minority floaterest00000
Total net income1,210 M1,378 M2,349 M975 M620 M
Preferred dividendsN/AN/AN/AN/AN/A
Net income available for common1,343 M1,518 M2,461 M1,702 M1,241 M
Depreciation33 M33 M24 M23 M23 M
Amortization33 M33 M24 M23 M23 M
Operating income before depreciation (EBITDA)1,624 M1,831 M2,754 M1,882 M1,430 M
Total Income available for floaterest expense (EBIT)00000
Basic EPS total3.423.893.351.321.49
Diluted EPS total3.423.893.351.321.49
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!